✦ LIBER ✦

Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience

✍ Scribed by José Ignacio Fortea-Ormaechea; Yago González-Lama; Begoña Casis; María Chaparro; Pilar López Serrano; Manuel Van Domselaar; Fernando Bermejo; Ramón Pajares; Ángel Ponferrada; María Isabel Vera; Pilar Martínez Montiel; Javier P. Gisbert; José Luis Pérez-Calle; Antonio López San Román; Luis Abreu; Luis Alberto Menchén; Ignacio Marín-Jiménez

Book ID: 116500991
Publisher: Elsevier Science
Year: 2011
Tongue: Spanish
Weight: 209 KB
Volume: 34
Category: Article
ISSN: 0210-5705
DOI: 10.1016/j.gastrohep.2011.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1313 Adalimumab for Luminal and Periana

W1313 Adalimumab for Luminal and Perianal Crohn's Disease in Real Practice: A Long-Term Multicenter Study of Effectiveness, Safety and Predictors of Response

✍ Ormaechea, Jose Ignacio Fortea; Gonzalez-Lama, Yago; Casis, Begoña; Chaparro, Ma 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 85 KB

OC.07.1 ADALIMUMAB IS EFFECTIVE IN THE T

OC.07.1 ADALIMUMAB IS EFFECTIVE IN THE TREATMENT OF ACTIVE LUMINAL CROHN'S DISEASE AND MUCOSAL HEALING: A SINGLE CENTER EXPERIENCE IN 170 PATIENTS

✍ R. Tambasco; P. Gionchetti; R. Brugnera; G. Straforini; C. Calabrese; G. Liguori 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 81 KB